154 related articles for article (PubMed ID: 19620330)
1. New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
Schneider I; Queenan AM; Markovska R; Markova B; Keuleyan E; Bauernfeind A
Antimicrob Agents Chemother; 2009 Oct; 53(10):4518-21. PubMed ID: 19620330
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
3. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
Markovska R; Schneider I; Keuleyan E; Bauernfeind A
Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
[TBL] [Abstract][Full Text] [Related]
4. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
Bae IK; Lee BH; Hwang HY; Jeong SH; Hong SG; Chang CL; Kwak HS; Kim HJ; Youn H
J Antimicrob Chemother; 2006 Aug; 58(2):315-9. PubMed ID: 16785225
[TBL] [Abstract][Full Text] [Related]
5. Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.
Zemelman C; Bello H; Domínguez M; González G; Mella S; Zemelman R
Diagn Microbiol Infect Dis; 2001; 40(1-2):41-3. PubMed ID: 11448562
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of the TEM-107 extended-spectrum β-lactamase in a Klebsiella pneumoniae isolate from South Korea.
Lee K; Yum JH; Yong D; Jeong SH; Rossolini GM; Docquier JD; Chong Y
Antimicrob Agents Chemother; 2011 Dec; 55(12):5930-2. PubMed ID: 21911565
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime.
Marchisio ML; Liebrenz KI; Méndez ELA; Di Conza JA
Braz J Microbiol; 2021 Dec; 52(4):1853-1863. PubMed ID: 34269999
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
Kristo I; Pitiriga V; Poulou A; Zarkotou O; Kimouli M; Pournaras S; Tsakris A
Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
[TBL] [Abstract][Full Text] [Related]
9. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
[TBL] [Abstract][Full Text] [Related]
10. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
11. ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17.
Cao V; Lambert T; Courvalin P
Antimicrob Agents Chemother; 2002 May; 46(5):1212-7. PubMed ID: 11959547
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province, China.
Wu H; Liu BG; Liu JH; Pan YS; Yuan L; Hu GZ
Genet Mol Res; 2012 Sep; 11(3):3357-64. PubMed ID: 23079829
[TBL] [Abstract][Full Text] [Related]
13. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
[TBL] [Abstract][Full Text] [Related]
14. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of baicalein with cefotaxime against Klebsiella pneumoniae through inhibiting CTX-M-1 gene expression.
Cai W; Fu Y; Zhang W; Chen X; Zhao J; Song W; Li Y; Huang Y; Wu Z; Sun R; Dong C; Zhang F
BMC Microbiol; 2016 Aug; 16(1):181. PubMed ID: 27502110
[TBL] [Abstract][Full Text] [Related]
16. Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan.
Yu WL; Pfaller MA; Winokur PL; Jones RN
Emerg Infect Dis; 2002 May; 8(5):522-4. PubMed ID: 11996691
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
Abrar S; Vajeeha A; Ul-Ain N; Riaz S
Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
[TBL] [Abstract][Full Text] [Related]
18. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Mohanty S; Gaind R; Ranjan R; Deb M
J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
[TBL] [Abstract][Full Text] [Related]
19. TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.
Rasheed JK; Anderson GJ; Queenan AM; Biddle JW; Oliver A; Jacoby GA; Bush K; Tenover FC
Antimicrob Agents Chemother; 2002 Jun; 46(6):2000-3. PubMed ID: 12019125
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
Chanal CM; Sirot DL; Labia R; Petit A; Morand A; Sirot JL; Cluzel RA
Antimicrob Agents Chemother; 1988 Nov; 32(11):1660-5. PubMed ID: 3075436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
